These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24150537)

  • 21. Impact of a predefined mediastinal ROI on inter-observer variability of planar ¹²³I-MIBG heart-to-mediastinum ratio.
    Verschure DO; Bongers V; Hagen PJ; Somsen GA; van Eck-Smit BL; Verberne HJ
    J Nucl Cardiol; 2014 Jun; 21(3):605-13. PubMed ID: 24493412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study.
    Nakajima K; Okuda K; Matsuo S; Yoshita M; Taki J; Yamada M; Kinuya S
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):113-9. PubMed ID: 22009380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of age on myocardial uptake of ¹²³I-mIBG in older adult subjects without coronary heart disease.
    Jacobson AF; Chen J; Verdes L; Folks RD; Manatunga DN; Garcia EV
    J Nucl Cardiol; 2013 Jun; 20(3):406-14. PubMed ID: 23483457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [
    Nuvoli S; Spanu A; Fravolini ML; Bianconi F; Cascianelli S; Madeddu G; Palumbo B
    Mol Imaging Biol; 2020 Jun; 22(3):703-710. PubMed ID: 31309370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Machine learning-based prediction of conversion coefficients for I-123 metaiodobenzylguanidine heart-to-mediastinum ratio.
    Okuda K; Nakajima K; Kitamura C; Ljungberg M; Hosoya T; Kirihara Y; Hashimoto M
    J Nucl Cardiol; 2023 Aug; 30(4):1630-1641. PubMed ID: 36740650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac
    Roberts G; Lloyd JJ; Petrides GS; O'Brien JT; Thomas AJ
    Biomed Phys Eng Express; 2019 Dec; 6(1):015011. PubMed ID: 33438599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collimator choice in cardiac SPECT with I-123-labeled tracers.
    Inoue Y; Shirouzu I; Machida T; Yoshizawa Y; Akita F; Minami M; Ohtomo K
    J Nucl Cardiol; 2004; 11(4):433-9. PubMed ID: 15295412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The heterogeneity of myocardial sympathetic innervation in normal subjects: an assessment by iodine-123 metaiodobenzylguanidine scintigraphy].
    D'Alto M; Maurea S; Basso A; Varrella P; Polverino W; Bianchi U; Bonelli A; Salvatore M; Chiariello M
    Cardiologia; 1998 Nov; 43(11):1231-6. PubMed ID: 9922590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of I-123 metaiodobenzylguanidine (¹²³I-MIBG) lung activity in subjects with heart failure in comparison to healthy control subjects.
    Gerson MC; Dwivedi AK; Abdallah M; Shukla R; Jacobson AF
    J Nucl Cardiol; 2013 Aug; 20(4):592-9. PubMed ID: 23636966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abdominal obesity, and not general obesity, is associated with a lower 123I MIBG heart-to-mediastinum ratio in heart failure patients with preserved ejection fraction.
    Sunaga A; Hikoso S; Yamada T; Yasumura Y; Uematsu M; Abe H; Nakagawa Y; Higuchi Y; Fuji H; Mano T; Kurakami H; Yamada T; Kitamura T; Sato T; Oeun B; Kida H; Kojima T; Sotomi Y; Dohi T; Okada K; Suna S; Mizuno H; Nakatani D; Sakata Y;
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):609-618. PubMed ID: 33715034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of acquisition time of planar cardiac (123)I-MIBG imaging on the late heart to mediastinum ratio.
    Dimitriu-Leen AC; Gimelli A; Al Younis I; Veltman CE; Verberne HJ; Wolterbeek R; Zandbergen-Harlaar S; Bax JJ; Scholte AJHA
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):326-332. PubMed ID: 26515715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability in Heart-to-Mediastinum Ratio from Planar
    Owenius R; Zanette M; Cella P
    J Nucl Med Technol; 2017 Dec; 45(4):297-303. PubMed ID: 29042467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical characteristics of low and medium energy collimators for 123I imaging and simultaneous dual-isotope imaging.
    Inoue Y; Shirouzu I; Machida T; Yoshizawa Y; Akita F; Doi I; Watadani T; Noda M; Yoshikawa K; Ohtomo K
    Nucl Med Commun; 2003 Nov; 24(11):1195-202. PubMed ID: 14569175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of high-energy photons on the spectrum of iodine-123 with low- and medium-energy collimators: consequences for imaging with 123I-labelled compounds in clinical practice.
    Dobbeleir AA; Hambÿe AS; Franken PR
    Eur J Nucl Med; 1999 Jun; 26(6):655-8. PubMed ID: 10369952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP].
    Yahara Y; Nomura Y; Okamoto S; Saitou K; Okamoto R; Makino K; Aoki S; Takeda K
    Kaku Igaku; 2000 May; 37(3):217-25. PubMed ID: 10860352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A European myocardial
    Verschure DO; Poel E; Nakajima K; Okuda K; van Eck-Smit BLF; Somsen GA; Verberne HJ
    J Nucl Cardiol; 2018 Aug; 25(4):1191-1197. PubMed ID: 28120154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Practical compensation method of downscattered component due to high energy photon in 123I imaging].
    Motomura N; Ichihara T; Takayama T; Aoki S; Kubo H; Takeda K
    Kaku Igaku; 1999 Dec; 36(9):997-1005. PubMed ID: 10659584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sympathetic reinnervation of cardiac allografts evaluated by 123I-MIBG imaging.
    Estorch M; Campreciós M; Flotats A; Marí C; Bernà L; Catafau AM; Ballester M; Narula J; Carrió I
    J Nucl Med; 1999 Jun; 40(6):911-6. PubMed ID: 10452305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of renal function on prognostic value of cardiac iodine-123 metaiodobenzylguanidine scintigraphy.
    Furuhashi T; Moroi M
    Ann Nucl Med; 2007 Jan; 21(1):57-63. PubMed ID: 17373337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.